DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Velcade (Bortezomib) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Death (419)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 419   Next >>

Possible Velcade side effects in

Reported by a physician from France on 2012-08-27

Patient:

Reactions: Death, Arthralgia, Radiotherapy

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Radiation Therapy NOS
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Revlimid
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Cisplatin
    Indication: Multiple Myeloma

Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide



Possible Velcade side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Death, Chalazion

Adverse event resulted in: death

Drug(s) suspected as cause:
Lenalidomide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Velcade
    Dosage: 2 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2009-08-13
    End date: 2012-01-03

Cyclophosphamide
    Indication: Multiple Myeloma

Other drugs received by patient: Bisphosphonates; Travoprost



Possible Velcade side effects in

Reported by a physician from Iran (Islamic Republic OF) on 2012-08-16

Patient:

Reactions: Death, Convulsion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Thalidomide



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Velcade side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Velcade side effects in

Reported by a physician from Spain on 2012-08-10

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from Canada on 2012-08-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from Canada on 2012-08-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from Canada on 2012-08-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from Canada on 2012-08-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from Canada on 2012-08-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 15 mg/kg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma



Possible Velcade side effects in

Reported by a physician from Canada on 2012-08-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 15 mg/kg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma



Possible Velcade side effects in

Reported by a physician from Canada on 2012-08-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Bevacizumab
    Dosage: 15 mg/kg, cyclic
    Indication: Multiple Myeloma



Possible Velcade side effects in

Reported by a physician from Canada on 2012-08-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Bevacizumab
    Dosage: 15 mg/kg, cyclic
    Indication: Multiple Myeloma



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017